Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription 26.07.2021 2 Anticancer Res 4 BMC Cancer 2 Clin Lung Cancer 1 Clin Nucl Med 2 Eur J Cardiothorac Surg 1 Hum Pathol 1 Int J Oncol 2 Int J Radiat Oncol Biol Phys 1 J Cancer Res Clin Oncol 2 J Nucl Med 1 J Thorac Cardiovasc Surg 2 J Thorac Oncol 1 JAMA Oncol 1 Lancet 1 Lung Cancer 2 Oncologist 3 PLoS One 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Anticancer Res

1. GIATROMANOLAKI A, Anestopoulos I, Panayiotidis MI, Mitrakas A, et al
   Prognostic Relevance of the Relative Presence of CD4, CD8 and CD20 Expressing Tumor Infiltrating Lymphocytes in Operable Non-small Cell Lung Cancer Patients.
   Anticancer Res. 2021;41:3989-3995.
   PubMed         Abstract available
   
   
2. LAFAUY P, Silapech A, Aksorn N, Sritularak B, et al
   Millettocalyxin B Inhibits Migratory Behavior of Lung Cancer Cells via Integrin alpha5 Suppression.
   Anticancer Res. 2021;41:3843-3849.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. SHEN H, Deng G, Chen Q, Qian J, et al
   The incidence, risk factors and predictive nomograms for early death of lung cancer with synchronous brain metastasis: a retrospective study in the SEER database.
   BMC Cancer. 2021;21:825.
   PubMed         Abstract available
   
   
4. HUNG A, Lee KM, Lynch JA, Li Y, et al
   Chemoradiation treatment patterns among United States Veteran Health Administration patients with unresectable stage III non-small cell lung cancer.
   BMC Cancer. 2021;21:824.
   PubMed         Abstract available
   
   
5. LUO H, Zhang Y, Qin G, Jiang B, et al
   LncRNA MCM3AP-AS1 sponges miR-148a to enhance cell invasion and migration in small cell lung cancer.
   BMC Cancer. 2021;21:820.
   PubMed         Abstract available
   
   
6. TANG Y, Zhang R, Li Y, Xu S, et al
   Genetic polymorphisms and haplotypes of ERCC1 and ERCC2 associated with quality of life, depression, and anxiety status among patients with lung cancer.
   BMC Cancer. 2021;21:842.
   PubMed         Abstract available
   
   

   
   Clin Lung Cancer

7. YANG Y, Deng L, Yang Y, Zhang T, et al
   Efficacy and Safety of Combined Brain Radiotherapy and Immunotherapy in Non-Small-Cell Lung Cancer With Brain Metastases: A Systematic Review and Meta-Analysis.
   Clin Lung Cancer. 2021 Jun 24. pii: S1525-7304(21)00160.
   PubMed         Abstract available
   
   
8. HENDRIKS LEL, Remon J, Besse B
   Dorian Gray Syndrome of Upfront Immunotherapy in Patients With Non-Small-Cell Lung Cancer and High PD-L1 Expression.
   Clin Lung Cancer. 2021 Jun 12. pii: S1525-7304(21)00149.
   PubMed        
   
   

   
   Clin Nucl Med

9. ZHANG J, Gao J, Dong A, Wang Y, et al
   Diffuse Linear Pattern of Pericardial FDG Activity in Pericardial Metastasis From Squamous Cell Lung Carcinoma.
   Clin Nucl Med. 2021 Jul 20. pii: 00003072-900000000-95919.
   PubMed         Abstract available
   
   

   
   Eur J Cardiothorac Surg

10. AOKAGE K, Suzuki K, Wakabayashi M, Mizutani T, et al
    Predicting pathological lymph node status in clinical stage IA peripheral lung adenocarcinoma.
    Eur J Cardiothorac Surg. 2021;60:64-71.
    PubMed         Abstract available
    
    
11. GOOSEMAN MR, Falcoz PE, Decaluwe H, Szanto Z, et al
    Morbidity and mortality of lung resection candidates defined by the American College of Chest Physicians as 'moderate risk': an analysis from the European Society of Thoracic Surgeons database.
    Eur J Cardiothorac Surg. 2021;60:91-97.
    PubMed         Abstract available
    
    

    
    Hum Pathol

12. YANAGAWA N, Shiono S, Endo M, Ogata SY, et al
    Programmed death ligand 1 protein expression is positively correlated with the solid predominant subtype, high MIB-1 labeling index, and p53 expression and negatively correlated with epidermal growth factor receptor mutations in lung adenocarcinoma.
    Hum Pathol. 2021;108:12-21.
    PubMed         Abstract available
    
    

    
    Int J Oncol

13. XIA H, Li Y, Lv X
    [Retracted] MicroRNA107 inhibits tumor growth and metastasis by targeting the BDNFmediated PI3K/AKT pathway in human nonsmall lung cancer.
    Int J Oncol. 2021;59.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

14. HOSKIN P
    Double the Target Volumes.
    Int J Radiat Oncol Biol Phys. 2021;109:846.
    PubMed        
    
    
15. SHAHI J, Poon I, Ung YC, Tsao M, et al
    Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:764-774.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

16. SUN J, Zhang J, Hu H, Qin H, et al
    Anti-tumour effect of neo-antigen-reactive T cells induced by RNA mutanome vaccine in mouse lung cancer.
    J Cancer Res Clin Oncol. 2021 Jul 21. pii: 10.1007/s00432-021-03735.
    PubMed         Abstract available
    
    

    
    J Nucl Med

17. NIEMEIJER AN, Oprea Lager DE, Huisman MC, Hoekstra OS, et al
    First-in-human study of (89)Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
    J Nucl Med. 2021 Jul 16. pii: jnumed.121.261926. doi: 10.2967/jnumed.121.261926.
    PubMed         Abstract available
    
    
18. ROHRICH M, Leitz D, Glatting FM, Wefers AK, et al
    Fibroblast Activation Protein specific PET/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study.
    J Nucl Med. 2021 Jul 16. pii: jnumed.121.261925. doi: 10.2967/jnumed.121.261925.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

19. KAMEL MK, Lee B, Harrison SW, Port JL, et al
    Sublobar resection is comparable to lobectomy for screen-detected lung cancer.
    J Thorac Cardiovasc Surg. 2021 Jul 1. pii: S0022-5223(21)01011.
    PubMed         Abstract available
    
    

    
    J Thorac Oncol

20. STEWART CA, Gay CM, Ramkumar K, Cargill KR, et al
    Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology.
    J Thorac Oncol. 2021 Jul 15. pii: S1556-0864(21)02294.
    PubMed         Abstract available
    
    
21. SMELTZER MP, Lee YS, Faris NR, Fehnel C, et al
    Trends in Accuracy and Comprehensiveness of Pathology Reports for Resected Non-small Cell Lung Cancer (NSCLC) in a High Mortality Area of the United States.
    J Thorac Oncol. 2021 Jul 16. pii: S1556-0864(21)02299.
    PubMed         Abstract available
    
    

    
    JAMA Oncol

22. JACOBSON JO
    Accompanying Patients in the Time of COVID-19.
    JAMA Oncol. 2021;7:971-972.
    PubMed        
    
    

    
    Lancet

23. THAI AA, Solomon BJ, Sequist LV, Gainor JF, et al
    Lung cancer.
    Lancet. 2021 Jul 14. pii: S0140-6736(21)00312.
    PubMed         Abstract available
    
    

    
    Lung Cancer

24. SPIRA AI, Tu H, Aggarwal S, Hsu H, et al
    A retrospective observational study of the natural history of advanced non-small-cell lung cancer in patients with KRAS p.G12C mutated or wild-type disease.
    Lung Cancer. 2021;159:1-9.
    PubMed         Abstract available
    
    

    
    Oncologist

25. IVANOVIC M, Knez L, Herzog A, Kovacevic M, et al
    Immunotherapy for metastatic non-small cell lung cancer: Real-world data from an academic Central and Eastern European centre.
    Oncologist. 2021 Jul 19. doi: 10.1002/onco.13909.
    PubMed         Abstract available
    
    
26. LEE Y, Cho Y, Park EY, Park SY, et al
    One-step polymerase chain reaction-free nanowire-based plasma cell-free DNA assay to detect EML4-ALK fusion and to monitor resistance in lung cancer.
    Oncologist. 2021 Jul 17. doi: 10.1002/onco.13902.
    PubMed         Abstract available
    
    

    
    PLoS One

27. XIAO K, Liu S, Xiao Y, Wang Y, et al
    Bioinformatics prediction of differential miRNAs in non-small cell lung cancer.
    PLoS One. 2021;16:e0254854.
    PubMed         Abstract available
    
    
28. PEDERSEN S, Kristensen AF, Falkmer U, Christiansen G, et al
    Increased activity of procoagulant factors in patients with small cell lung cancer.
    PLoS One. 2021;16:e0253613.
    PubMed         Abstract available
    
    
29. ARIK A, Dodd E, Cairns A, Streftaris G, et al
    Socioeconomic disparities in cancer incidence and mortality in England and the impact of age-at-diagnosis on cancer mortality.
    PLoS One. 2021;16:e0253854.
    PubMed         Abstract available
    
    

    
    Thorax

30. ARAGHI M, Fidler-Benaoudia M, Arnold M, Rutherford M, et al
    International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study.
    Thorax. 2021 Jul 19. pii: thoraxjnl-2020-216555.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: